Stay updated on OMS721 in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the OMS721 in IgA Nephropathy Clinical Trial page.

Latest updates to the OMS721 in IgA Nephropathy Clinical Trial page
- Check6 days agoChange DetectedThe page's revision tag was updated to v3.5.5, replacing the previous v3.5.4. This indicates a minor update to the page template or metadata rather than to core content.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedA new revision tag 'Revision: v3.5.4' was added and the previous 'Revision: v3.5.3' tag was removed to reflect an updated revision history.SummaryDifference0.0%

- Check42 days agoChange DetectedThe Taiwan site entry changed from Taoyuan, Taiwan, 333 to Taoyuan City, Taiwan, 333, clarifying the precise municipal designation of the location.SummaryDifference0.0%

- Check49 days agoChange DetectedUpdates the ClinicalTrials.gov page version from `Revision: v3.5.2` to `Revision: v3.5.3`.SummaryDifference0.0%

- Check56 days agoChange DetectedRevision tag updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check78 days agoChange DetectedAdded IgA glomerulonephritis as a related term and included the Genetic and Rare Diseases Information Center as a resource.SummaryDifference0.1%

Stay in the know with updates to OMS721 in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OMS721 in IgA Nephropathy Clinical Trial page.